Primary Leiomyosarcoma of the Superior Vena Cava: A Rare Case Report.

IF 1.6 Q2 MEDICINE, GENERAL & INTERNAL
Andrey Ryabov, Stansilav Cygelnikov, Oleg Pikin, Oleg Aleksandrov, Vladimir Bagrov, Aleksandr Gusev, Evgeniy Toneev, Viktoriya Surkova, Aznaur Dotdaev
{"title":"Primary Leiomyosarcoma of the Superior Vena Cava: A Rare Case Report.","authors":"Andrey Ryabov, Stansilav Cygelnikov, Oleg Pikin, Oleg Aleksandrov, Vladimir Bagrov, Aleksandr Gusev, Evgeniy Toneev, Viktoriya Surkova, Aznaur Dotdaev","doi":"10.30476/ijms.2026.109892.4532","DOIUrl":null,"url":null,"abstract":"<p><p>Leiomyosarcoma of the superior vena cava (SVC) is an exceptionally rare vascular tumor. Fewer than 20 cases were reported worldwide. Because of the nonspecific nature of the presenting symptoms and their deep mediastinal location, a pre-operative diagnosis is often difficult or impossible. A 63-year-old woman presented with progressive facial and upper-limb edema. Computed tomography (CT) demonstrated a hyper vascular intraluminal mass originating in the SVC and extending towards the right atrium. Percutaneous biopsy was considered unsafe due to the risk of hemorrhage. Therefore, radical surgical resection of the SVC and brachiocephalic veins with xenopericardial patch reconstruction was performed. Histological and immunohistochemical examination confirmed a grade two leiomyosarcoma. No adjuvant therapy was given. At 8-month follow-up, there was no evidence of recurrence. Primary SVC leiomyosarcoma is a rare and diagnostically challenging condition. Pre-operative biopsy is often not feasible, and radical <i>en bloc</i> resection with vascular reconstruction remains the cornerstone of treatment, offering the best chance of recurrence-free survival. Histopathological confirmation is required to establish the diagnosis, and the role of adjuvant therapy remains uncertain.</p>","PeriodicalId":14510,"journal":{"name":"Iranian Journal of Medical Sciences","volume":"51 7","pages":"523-527"},"PeriodicalIF":1.6000,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13451530/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Iranian Journal of Medical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.30476/ijms.2026.109892.4532","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Leiomyosarcoma of the superior vena cava (SVC) is an exceptionally rare vascular tumor. Fewer than 20 cases were reported worldwide. Because of the nonspecific nature of the presenting symptoms and their deep mediastinal location, a pre-operative diagnosis is often difficult or impossible. A 63-year-old woman presented with progressive facial and upper-limb edema. Computed tomography (CT) demonstrated a hyper vascular intraluminal mass originating in the SVC and extending towards the right atrium. Percutaneous biopsy was considered unsafe due to the risk of hemorrhage. Therefore, radical surgical resection of the SVC and brachiocephalic veins with xenopericardial patch reconstruction was performed. Histological and immunohistochemical examination confirmed a grade two leiomyosarcoma. No adjuvant therapy was given. At 8-month follow-up, there was no evidence of recurrence. Primary SVC leiomyosarcoma is a rare and diagnostically challenging condition. Pre-operative biopsy is often not feasible, and radical en bloc resection with vascular reconstruction remains the cornerstone of treatment, offering the best chance of recurrence-free survival. Histopathological confirmation is required to establish the diagnosis, and the role of adjuvant therapy remains uncertain.

上腔静脉原发性平滑肌肉瘤1例报告。
摘要上腔静脉平滑肌肉瘤是一种罕见的血管肿瘤。全世界报告的病例不到20例。由于表现症状的非特异性和深纵隔位置,术前诊断往往是困难的或不可能的。一名63岁女性,表现为进行性面部和上肢水肿。计算机断层扫描(CT)显示一个起源于SVC并向右心房延伸的高血管腔内肿块。由于出血的风险,经皮活检被认为是不安全的。因此,我们采用异种心包补片重建术根治性切除SVC和头臂静脉。组织学及免疫组化检查证实为二级平滑肌肉瘤。未给予辅助治疗。随访8个月,无复发迹象。原发性SVC平滑肌肉瘤是一种罕见且具有诊断挑战性的疾病。术前活检通常是不可行的,血管重建的根治性整体切除仍然是治疗的基石,提供了无复发生存的最佳机会。需要组织病理学证实才能确定诊断,辅助治疗的作用仍不确定。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Iranian Journal of Medical Sciences
Iranian Journal of Medical Sciences MEDICINE, GENERAL & INTERNAL-
CiteScore
3.20
自引率
0.00%
发文量
84
审稿时长
12 weeks
期刊介绍: The Iranian Journal of Medical Sciences (IJMS) is an international quarterly biomedical publication, which is sponsored by Shiraz University of Medical Sciences. The IJMS intends to provide a scientific medium of com­muni­cation for researchers throughout the globe. The journal welcomes original clinical articles as well as clinically oriented basic science re­search experiences on prevalent diseases in the region and analysis of various regional problems.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书